These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 21465318)

  • 1. Breast cancer proteomics: a review for clinicians.
    Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].
    Gonçalves A; Bertucci F; Birnbaum D; Borg JP
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():23-6. PubMed ID: 17669349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of breast cancer: principles and potential clinical applications.
    Bertucci F; Birnbaum D; Goncalves A
    Mol Cell Proteomics; 2006 Oct; 5(10):1772-86. PubMed ID: 16733261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of functional proteomics in breast cancer.
    Chae YK; Gonzalez-Angulo AM
    Oncologist; 2014 Apr; 19(4):328-35. PubMed ID: 24664486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic evaluation of core biopsy specimens from breast lesions.
    Bisca A; D'Ambrosio C; Scaloni A; Puglisi F; Aprile G; Piga A; Zuiani C; Bazzocchi M; Di Loreto C; Paron I; Tell G; Damante G
    Cancer Lett; 2004 Feb; 204(1):79-86. PubMed ID: 14744537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics in cancer.
    Reymond MA; Schlegel W
    Adv Clin Chem; 2007; 44():103-42. PubMed ID: 17682341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELDI-TOF serum proteomics and breast cancer: which perspective?
    Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
    Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALDI mass spectrometry in prostate cancer biomarker discovery.
    Flatley B; Malone P; Cramer R
    Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer.
    Gast MC; Zapatka M; van Tinteren H; Bontenbal M; Span PN; Tjan-Heijnen VC; Knol JC; Jimenez CR; Schellens JH; Beijnen JH
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1773-83. PubMed ID: 21913038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT).
    Chen EI; Hewel J; Felding-Habermann B; Yates JR
    Mol Cell Proteomics; 2006 Jan; 5(1):53-6. PubMed ID: 16272560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
    Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
    Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
    Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I
    Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.
    Xu SG; Yan PJ; Shao ZM
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1545-56. PubMed ID: 20155427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer.
    Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP
    Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
    Zeidan BA; Townsend PA
    Breast Cancer Res; 2008; 10(3):107. PubMed ID: 18644101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
    Brozkova K; Budinska E; Bouchal P; Hernychova L; Knoflickova D; Valik D; Vyzula R; Vojtesek B; Nenutil R
    Breast Cancer Res; 2008; 10(3):R48. PubMed ID: 18510725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of breast carcinoma.
    Somiari RI; Somiari S; Russell S; Shriver CD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of gliomas.
    Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
    Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.